<div id="readability-page-1"><article>Jupiter, Florida--(Newsfile Corp. - May 4, 2026) - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, announced today that it will be participating in the Market Movers Investor Summit on Tuesday May 5, 2026. The presentation will take place at 09:00 AM ET at the historic Bank of New York. Christer Rosén, Chairman and CEO, will be giving the presentation.The Market Movers Investor Summit is a premier, high-access event on Wall Street. The Inaugural program features fireside chats with Alex Rodriguez, Chairman and CEO of A-Rod Corp, and Grant Cardone, CEO of Cardone Capital, in addition to company presentations and one-on-one meetings throughout the day.Event Details:<ul><li>Summit Dates: May 5, 2026 </li> <li>Company Presentation: Tuesday, May 5, 2026 </li> <li>Time: 09:00 AM ET </li> <li>Location: 48 Wall Street, New York, NY (The original Bank of New York)</li></ul>Request an invitation to attend at www.marketmoverssummit.com.Summary of Market Movers Investor SummitThe 2026 Market Movers Investor Summit begins on May 4th with a kickoff party at the legendary Delmonico’s, followed by a full day of programming on May 5th. The summit brings together public and private company executives, fund managers, and family offices for a focused, high-caliber experience. The agenda includes company presentations, exclusive fireside chats and keynote sessions, a pop-up lunch from the legendary Katz Delicatessen and a surprise musical guest.About Jupiter Neurosciences, Inc.Jupiter Neurosciences is a clinical-stage pharmaceutical company pursuing a dual-path strategy to address neuroinflammation and promote healthy aging. The Company is advancing a therapeutic pipeline targeting central nervous system (CNS) disorders and rare diseases, while also expanding into the consumer longevity market with its Nugevia™ product line. Both efforts are powered by JOTROL™, Jupiter's proprietary, enhanced resveratrol formulation that has demonstrated improved bioavailability in clinical studies. The Company's prescription pipeline is focused broadly on CNS disorders, presently with a Phase IIa in Parkinson's disease, including indications such as Alzheimer's Disease, Mucopolysaccharidoses Type I, Friedreich's Ataxia, and MELAS.About Market MoversMarket Movers is a next-generation investor conference designed for people responsible for capital, growth, and strategic outcomes. Hosted on Wall Street inside the original Bank of New York, the event brings together public &amp; company leaders, investors, real estate principals, founders, and operators for a focused, high-access experience. The emphasis is on meaningful conversations, real connections, and perspectives that extend beyond a single market or asset class.To learn more about the Market Movers Investor Summit, visit: https://www.marketmoverssummit.comFor further information on Jupiter Neurosciences, Inc. Christer Rosén (561) 406-6154 ir@jupiterneurosciences.com https://jupiterneurosciences.com<img src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/295754/375?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1" height="1" original-src="https://imageproxy.pbkrs.com/https://api.newsfilecorp.com/newsinfo/295754/375"/></article></div>

JUNS

ARKG

Jupiter Neurosciences, Inc. (NASDAQ: JUNS) will present at the Market Movers Investor Summit on May 5, 2026, at 09:00 AM ET in New York. CEO Christer Rosén will lead the presentation. The summit features discussions with notable figures like Alex Rodriguez and Grant Cardone, along with company presentations and networking opportunities. Jupiter Neurosciences focuses on developing JOTROL™, a resveratrol-based platform targeting CNS disorders and promoting healthy aging. The event aims to foster connections among executives, investors, and industry leaders.

StockTitan

Jupiter Neurosciences

Health Care Select Sector SPDR

Ark Genomic Revolution ETF

ALPS Medical Breakthrough

Direxion S&P Biotech Bull 3X

VG Health

iShares Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

Invesco Biotechnology & Genome ETF

VanEck Biotech ETF

Proshares Ultra Nasdaq Biotech

iShares Global Healthcare

SPDR S&P Biotech

Jupiter Neurosciences, Inc. to Present at The Market Movers Investor Summit | JUNS Stock News